ALVARADO PARKWAY INSTITUTE — History
CCN 054075 | 3-year financial timeline | COVID resilience: 31/100
🛡️ Public data only — no PHI permitted on this instance.
$32M
Latest Revenue (FY2022)
-1.6%
Revenue CAGR (3yr)
-6.6%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $33M | $31M | $32M | +2.6% | -1.6% |
| Operating Expenses | $32M | $30M | $34M | +13.8% | +3.5% |
| Operating Margin | 3.6% | 3.9% | -6.6% | -268.7% | +0.0% |
| Net Income | $1M | $1M | $-2M | -273.1% | +0.0% |
| Licensed Beds | 66 | 66 | 66 | +0.0% | +0.0% |
| Total Patient Days | 21,950 | 19,794 | 20,579 | +4.0% | -3.2% |
| Medicare Day % | 22% | 23% | 18% | -21.8% | -9.7% |
| Medicaid Day % | 23% | nan% | nan% | +nan% | +nan% |
COVID Impact & Recovery
Resilience Score: 31/100 — Distressed — significant COVID damage
Revenue recovery from FY2020 to FY2022: -3.1% ($33M → $32M)
FY2020 captured the initial COVID shock. Slow recovery suggests structural challenges beyond COVID.
Trend Summary
Revenue▼ Declining
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
-1.6%
This Hospital
+7.6%
State Avg
Latest Margin
-6.6%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $31M | -11.6% |
| FY2024 (proj) | $31M | -16.7% |
| FY2025 (proj) | $30M | -21.8% |